Cambi recorded order intake of NOK 554 million in the second quarter, lifting the order backlog to NOK 1.5 billion at the end of June. New awards included THP projects in India and New Zealand, as well as Grønn Vekst's renewed biosolids handling contract in Bergen.
Revenue was NOK 265 million, compared with NOK 342 million in the second quarter of 2025. EBITDA was NOK 26 million, down from NOK 75 million one year earlier.
Comment from Cambi's CEO, Per Lillebø:
"Cambi had a very active second quarter commercially, with important wins in India, New Zealand, and Norway. Several large Technology projects are approaching completion, so lower revenue and earnings this quarter reflect our position in the delivery cycle rather than a change in market opportunity. The order backlog is increasing, project execution is progressing well, and the focus is on delivering what we have won while continuing to develop the next opportunities."
Key highlights - in NOK million
Q2 2026 (Q2 2025)
Revenue: 265 (342)
EBITDA: 26 (75)
Order intake: 554 (102) Order backlog: 1,479 (938)
H1 2026 (H1 2025)
Revenue: 444 (567)
EBITDA: 49 (89)
Order intake: 902 (272)
Operating cash flow was NOK 156 million, and cash and cash equivalents reached NOK 388 million at quarter's end after NOK 48 million in dividends paid during the quarter.
The UK remains Cambi's strongest near-term market. Management maintains its view that 2026 operating profit will be lower than in 2025, while the long-term growth outlook remains positive.
Webcast
Cambi will present its second-quarter 2026 results tomorrow, Wednesday, 19 August, at 10:00 am CEST. The presentation will be webcast live through Cambi's investor portal at investors.cambi.com/events.
Questions to management may be submitted by scanning the QR code shown on screen. A dedicated Q&A session will follow the presentation.
The webcast recording and transcript will be published on Cambi's website shortly after the event.
The quarterly report and an accompanying Excel file with financial statements and supplementary historical data for the two business segments, order intake, and order backlog, are available at https://investors.cambi.com/results-and-reports. The report is also available through NewsWeb.
For more information, please contact:
- Per Lillebø, CEO, +47 918 88 365, per.lillebo@cambi.com
- Mats Tristan Tjemsland, CFO, +47 920 67 094, mats.tjemsland@cambi.com
This information is published in accordance with Cambi ASA's continuing obligations as a listed company set out in the Norwegian Securities Trading Act section 5-12.
About Cambi
Cambi is a global provider of technologies and services for water and wastewater treatment and organic materials management. Since 1992, the company has served utilities, municipalities, and industrial customers.
The thermal hydrolysis process (THP) remains its core technology. More than 100 Cambi THP systems are in operation across more than 25 countries on 6 continents. The process is used in conjunction with anaerobic digestion to enhance the treatment of organic feedstocks, increase biogas production, improve dewatering, and reduce final biosolids volumes. It can be integrated into new and existing facilities and supports downstream routes ranging from land application to thermal processing.
The wider portfolio includes technologies for nutrient recovery and digestion, lifecycle services, biosolids logistics and land application, composting, and soil production.
Cambi ASA is listed on Euronext Growth Oslo under the ticker CAMBI. Find out more at cambi.com.